mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.003 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
0.004 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.005 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.005 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.006 |